Lyell Immunopharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.

About LYEL

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D.

CEO

Lynn Seely

CEOLynn Seely

Employees

300

Employees300

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2018

Founded2018

Employees

300

Employees300

LYEL Key Statistics

Market cap

240.72M

Market cap240.72M

Price-Earnings ratio

-0.51

Price-Earnings ratio-0.51

Dividend yield

—

Dividend yield—

Average volume

42.13K

Average volume42.13K

High today

$12.74

High today$12.74

Low today

$12.36

Low today$12.36

Open price

$12.65

Open price$12.65

Volume

28.03K

Volume28.03K

52 Week high

$32.00

52 Week high$32.00

52 Week low

$7.65

52 Week low$7.65

LYEL News

TipRanks 2d

Lyell Immunopharma CFO Resignation Announced

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

People also own

Based on the portfolios of people who own LYEL. This list is generated using Robinhood data, and it’s not a recommendation.